Immunotherapy-resistant acute lymphoblastic leukemia cells exhibit reduced CD19 and CD22 expression and BTK pathway dependencySarah Aminov, Amit Verma, Veronika Polishchuk et al.|Journal of Clinical Investigation|2024Cited by 20
Resistance to CD19 Immunotherapy in B-Cell ALL Is Associated with Loss of CD19 and CD22 and an Enhanced Vulnerability to B Cell Receptor Signaling InhibitionSarah Aminov, Amit Verma, Orsi Giricz et al.|Blood|2022Cited by 3